JPML Centralizes Lipitor Diabetes Suits In SC
The JPML said in an order that a spate of related filings against Pfizer had caused it to reconsider its July order declining to centralize the suits. The panel said that plaintiffs’ counsel has increased significantly since then and that informal coordination and cooperation are no longer practicable.
"Upon re-evaluation, we...
To view the full article, register now.